In the future, it would be interesting to determine if the nuclear accumulation of INF2 and NUMA1, as well as the splicing and protein defects of CAPZB and PALM, in DMSXL cells affect the organization and dynamics of the cytoskeleton, and how they correlate to clinical features of DM1. This evidence concerns the gene CAPZB and myotonic dystrophy type 1.